MedPath

Evaluating of therapeutic results of metacarpal fixatio

Phase 3
Conditions
transverse or obligue metacarpal fracture.
Unspecified fracture of metacarpal bone
S62.20
Registration Number
IRCT20230102057026N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

age between 18-50 years
Isolated closed transverse or oblique metacarpal fractures
candidacy for surgical treatment
informed consent to enter the study

Exclusion Criteria

simultaneous fracture in the upper limb or multiple trauma
unwillingness to participate in the study
non-referral for follow-up treatment
malignancy
osteoarthritis
major systemic disease
taking drugs that affect fracture healing, such as steroid and anticancer drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: 3 and 12 months after surgery. Method of measurement: sf36 questionnaire.;Disability. Timepoint: 3 and 12 months after surgery. Method of measurement: DASH questionnaire.;Infection. Timepoint: 3 and 12 months after surgery. Method of measurement: physical exammination.;Range of motion. Timepoint: 3 and 12 months after surgery. Method of measurement: physical exammination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath